Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan R Leloux

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
South Dakota Medicine : the Journal of the South Dakota State Medical Association|October 1, 2011
Medication use in the elderly: challenges and considerationsMegan R Leloux, Matthew T Malone, Eric C Kutscher
Therapeutic Drug Monitoring|June 6, 2024
Making Clozapine Therapeutic Drug Monitoring Essential for Optimal Patient CareJonathan G Leung, Katie N Bye, Megan R Leloux, et al.
Pharmacotherapy|August 30, 2008
Reduction in adverse symptoms as blood pressure becomes controlledCynthia A Weber, Megan R Leloux, Barry L Carter, et al.
Journal of the American Pharmacists Association : Japha|June 6, 2022
Iatrogenic clozapine intoxication after hospital admission: A case-based rationale for an inpatient pharmacy clozapine monitoring serviceJonathan G Leung, Daniela B Rakocevic, Shelby N Courtis, et al.
Neurology. Clinical Practice|June 1, 2018
IV fosphenytoin in obese patients: Dosing strategies, safety, and efficacySarah L Clark, Megan R Leloux, Ross A Dierkhising, et al.
Schizophrenia Research|March 18, 2018
Clozapine-induced cardiomyopathy and myocarditis monitoring: A systematic reviewKristen N Knoph, Robert J Morgan, Brian A Palmer, et al.
Therapeutic Drug Monitoring|December 11, 2025
Perceptions, Use, and Barriers of Clozapine Therapeutic Drug Monitoring in the United States: A Multidisciplinary Survey StudyJonathan G Leung, Morgan Gatzlaff, Megan R Leloux, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
South Dakota Medicine : the Journal of the South Dakota State Medical Association|October 1, 2011
Medication use in the elderly: challenges and considerationsMegan R Leloux, Matthew T Malone, Eric C Kutscher
Therapeutic Drug Monitoring|June 6, 2024
Making Clozapine Therapeutic Drug Monitoring Essential for Optimal Patient CareJonathan G Leung, Katie N Bye, Megan R Leloux, et al.
Pharmacotherapy|August 30, 2008
Reduction in adverse symptoms as blood pressure becomes controlledCynthia A Weber, Megan R Leloux, Barry L Carter, et al.
Journal of the American Pharmacists Association : Japha|June 6, 2022
Iatrogenic clozapine intoxication after hospital admission: A case-based rationale for an inpatient pharmacy clozapine monitoring serviceJonathan G Leung, Daniela B Rakocevic, Shelby N Courtis, et al.
Neurology. Clinical Practice|June 1, 2018
IV fosphenytoin in obese patients: Dosing strategies, safety, and efficacySarah L Clark, Megan R Leloux, Ross A Dierkhising, et al.
Schizophrenia Research|March 18, 2018
Clozapine-induced cardiomyopathy and myocarditis monitoring: A systematic reviewKristen N Knoph, Robert J Morgan, Brian A Palmer, et al.
Therapeutic Drug Monitoring|December 11, 2025
Perceptions, Use, and Barriers of Clozapine Therapeutic Drug Monitoring in the United States: A Multidisciplinary Survey StudyJonathan G Leung, Morgan Gatzlaff, Megan R Leloux, et al.
Pageof 1